Read More Healthcare Industry News Telix Pharmaceuticals gains U.S. Medicare reimbursement code for Gozellix prostate cancer imaging agent Telix Pharmaceuticals’ Gozellix secures U.S. reimbursement code, opening access to PSMA-PET prostate cancer imaging. Find out what’s next for its rollout and impact. byPallavi MadhirajuJuly 9, 2025